| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.46 | 0.1 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.17 | 0.1 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |